Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.
Revolutionizing Delivery Through Automation, Digitalization and Regulatory Transformation to Reduce Vein-to-Vein Time, Cost of Goods & Enhance Patient Access
Welcome to the Inaugural Decentralized Manufacturing for Cell Therapy Summit
Advance Scalability, Accessibility & Affordability of Autologous Cell Therapies
As the cell therapy space bears witness to an increasing number of autologous therapies gaining regulatory approval, the essential role of the manufacturing ecosystem has never been clearer. It is business critical for cell therapy drug developers to have a robust strategy for scale up whilst overcoming the labour and cost intensive nature of batch manufacturing to reduce the cost of goods.
Enter the timely arrival of the inaugural Decentralized Manufacturing for Cell Therapy Summit, the pioneering forum for cell therapy leaders across manufacturing to gain practical insights into the strategic adoption of decentralized manufactured cell therapy products in order to reduce manufacturing turnaround time and overcome commercial patient access barriers.